Feasibility of Teleglaucoma Versus Conventional Clinical Evaluation for Diagnostic Accuracy and Management Recommendations in Patients With Glaucoma
Teleglaucoma
TELEGLAUCOMA: THE NJ HEALTH FOUNDATION STUDY a Prospective, Single Site, Masked Study Comparing the Diagnostic Accuracy and Management Recommendations of Teleglaucoma to Conventional Clinical Care in Patients With Glaucoma
1 other identifier
interventional
107
0 countries
N/A
Brief Summary
Telemedicine allows screening of subjects with limited access to eye care. Failure of screenees to come for full examination was identified as a serious problem. Teleglaucoma should allow a single physician access to screenees in real time. The investigators aim to test the technical feasibility of developing a system for teleglaucoma that will allow a physician real time access to patient information and images and compare it to traditional physical presence evaluation in glaucoma clinics. This system can be applied during telemedicine for glaucoma and other vision threatening diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 21, 2018
CompletedFirst Posted
Study publicly available on registry
July 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedAugust 23, 2021
August 1, 2021
3.1 years
May 21, 2018
August 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of diagnosis and management in Teleglaucoma and conventional care
Qualitative categorical outcome: Glaucoma Diagnosis, Management and follow up are clinical determinations by the investigator that are based on the overall clinical evaluation of the subject Diagnosis: A. no glaucoma B. confirmed glaucoma Management: A. maintain current therapy, B. advance therapy (additional glaucoma medication or surgical glaucoma intervention), C. no therapy needed Follow up: A. urgent (less than 4 weeks from time of evaluation) B. routine (more than 4 weeks from time of evaluation)
24 months
Secondary Outcomes (4)
Assessment of diagnostic tools during teleglaucoma: Visual acuity
12 months
Assessment of diagnostic tools during teleglaucoma: Tonometry
12 months
Assessment of diagnostic tools during tele glaucoma: Optic nerve
12 months
Assessment of diagnostic tools during tele glaucoma: Optical Coherence Tomography
12 months
Study Arms (1)
Tele-Glaucoma arm
EXPERIMENTALSubjects enrolled in tele-glaucoma arm for remote assessment
Interventions
Subjects are evaluated through a teleglaucoma protocol then by physical presence in a glaucoma clinic
Eligibility Criteria
You may qualify if:
- Adult patients with glaucoma or who are glaucoma suspects
You may not qualify if:
- Physical limitations precluding image acquisition like the inability to position for imaging or the inability to acquire images/testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rutgers Universitylead
- New Jersey Health Foundationcollaborator
Related Publications (1)
Chandrasekaran S, Kass W, Thangamathesvaran L, Mendez N, Khouri P, Szirth BC, Khouri AS. Tele-glaucoma versus clinical evaluation: The New Jersey Health Foundation Prospective Clinical Study. J Telemed Telecare. 2020 Oct;26(9):536-544. doi: 10.1177/1357633X19845273. Epub 2019 May 28.
PMID: 31138016BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Albert S Khouri, MD
Rutgers University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking Details
- Investigators in teleglaucoma and conventional glaucoma clinics are masked to one another
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 21, 2018
First Posted
July 16, 2018
Study Start
August 1, 2016
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
August 23, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share